These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 1539284
1. Influence of immunosuppressive therapy on infectious complications in renal transplant recipients. Klauser R, Zlabinger GJ, Traindl O, Franz M, Watschinger B, Pohanka E, Kudlacek S, Kovarik J. Transplant Proc; 1992 Feb; 24(1):292-4. PubMed ID: 1539284 [No Abstract] [Full Text] [Related]
2. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation. Kitabayashi K, Munn SR, Sterioff S. Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964 [No Abstract] [Full Text] [Related]
9. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T, Kapischke M, Busing M. Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475 [Abstract] [Full Text] [Related]
10. Evaluation of infections in renal transplant recipients treated with cyclosporine. Carmellini M, Romagnoli J, Pietrabissa A, Di Stefano R, Oleggini M, Rindi P, Rizzo G, Mosca F. Transplant Proc; 1994 Oct; 26(5):2658-9. PubMed ID: 7940832 [No Abstract] [Full Text] [Related]
11. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation. Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P. Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207 [No Abstract] [Full Text] [Related]
12. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. Stratta RJ, Taylor RJ, Weide LG, Sindhi R, Sudan D, Castaldo P, Cushing KA, Frisbie K, Radio SJ. Transplant Proc; 1996 Apr; 28(2):917-8. PubMed ID: 8623461 [No Abstract] [Full Text] [Related]
14. Treatment of steroid resistant acute rejection after renal transplantation. Oh CK, Kim YS, Kim MS, Kim SI, Park K. Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737 [No Abstract] [Full Text] [Related]
15. Triple drug maintenance therapy in renal transplantation. Pallardó LM, Sánchez J, Hernandez M, Górriz JL, Sánchez P, Beneyto I, Rochera A. Transplant Proc; 1992 Feb; 24(1):58-9. PubMed ID: 1539343 [No Abstract] [Full Text] [Related]